Adynxx, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ADYX research report →
About the company
Adynxx, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating and commercializing novel transcription factor decoy technologies to combat pain and inflammatory conditions. Central to its efforts is the AYX platform of transcription factor decoys, which includes brivoligide, currently progressing through Phase II clinical development for reducing post-surgical discomfort.
- CEO
- Richard Orr
- IPO
- 1998
- Employees
- 6
- HQ
- San Francisco, CA, US
Price Chart
- Market Cap
- $581
- P/E
- -0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- 2.60
- Div Yield
- 0.00%
- Gross Margin
- 22.38%
- Op Margin
- -238.99%
- Net Margin
- -379.83%
- ROE
- -70.38%
- ROIC
- -63.78%
- Revenue
- $2.22M · 9.76%
- Net Income
- $-8,417,000 · 67.26%
- EPS
- $-10.26 · 71.45%
- Op Income
- $-5,296,000
- FCF YoY
- 10.52%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -8.54
- Avg Volume
- 51
Get TickerSpark's AI analysis on ADYX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 22, 19 | FLESHER GREGORY J. | other | 0 |
| May 29, 19 | GONZALEZ DINA | other | 26,358 |
| May 29, 19 | GONZALEZ DINA | other | 1,577 |
| May 29, 19 | GONZALEZ DINA | other | 1,577 |
| May 3, 19 | TPG Group Holdings (SBS) Advisors, Inc. | other | 0 |
| May 3, 19 | DP VIII Associates, L.P. | other | 0 |
| May 3, 19 | Domain Partners VIII, L.P. | other | 0 |
| May 3, 19 | ABEL STAN E | other | 54,117 |
| May 3, 19 | ABEL STAN E | other | 27,940 |
| May 3, 19 | ABEL STAN E | other | 198 |
Our ADYX coverage
Recent articles, reports, and earnings notes.
No research on ADYX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ADYX report →Similar companies
Peers in the same neighborhood.